HopeStage
Back to all studies
CompletedNCT03529409

Supporting HIV Medication Adherence and Substance-Use Care in South Africa

About this titleRead the official source — NCT03529409
Behavioural studyAges 18–65United States + South AfricaAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
College Park and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 30, 2018
Recruitment status
Completed
Enrollment listed in the registry
66
Sponsor
University of Maryland, College Park
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural
Locations
United States, South Africa
Age range
From 18 Years to 65 Years
Official registry ID
NCT03529409
Official title
Show the full official title

Hybrid Effectiveness-Implementation Trial for ART Adherence and Substance Use in HIV Care in South Africa

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

College Park, United States · Cape Town, South Africa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Maryland, College Park, a university.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies